Posted by admin on Jul 6th, 2022
State of Alaska Department of Revenue lowered its position in Proto Labs, Inc. (NYSE:PRLB – Get Rating) by 1.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,189 shares of the industrial products company’s stock after selling 345 shares during the period. State of Alaska Department of Revenue’s holdings in Proto Labs were worth $1,015,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. Antonetti Capital Management LLC grew its position in Proto Labs by 84.5% during the fourth quarter. Antonetti Capital Management LLC now owns 524 shares of the industrial products company’s stock valued at $51,000 after buying an additional 240 shares during the period. Concord Wealth Partners grew its position in Proto Labs by 129.3% during the fourth quarter. Concord Wealth Partners now owns 633 shares of the industrial products company’s stock valued at $33,000 after buying an additional 357 shares during the period. Signaturefd LLC grew its position in Proto Labs by 1,680.6% during the fourth quarter. Signaturefd LLC now owns 552 shares of the industrial products company’s stock valued at $28,000 after buying an additional 521 shares during the period. CarsonAllaria Wealth Management Ltd. bought a new position in Proto Labs during the fourth quarter valued at about $28,000. Finally, Nisa Investment Advisors LLC grew its position in Proto Labs by 227.3% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,080 shares of the industrial products company’s stock valued at $54,000 after buying an additional 750 shares during the period. Institutional investors own 93.35% of the company’s stock.
A number of equities analysts have weighed in on PRLB shares. Craig Hallum cut their target price on shares of Proto Labs from $56.00 to $50.00 in a research report on Monday, May 9th. StockNews.com started coverage on shares of Proto Labs in a research report on Thursday, March 31st. They set a “hold” rating for the company.
Shares of NYSE:PRLB opened at $49.59 on Wednesday. Proto Labs, Inc. has a twelve month low of $39.36 and a twelve month high of $93.66. The firm has a market capitalization of $1.36 billion, a PE ratio of 39.36 and a beta of 1.34. The company has a 50-day moving average price of $46.06 and a two-hundred day moving average price of $49.71.
Proto Labs (NYSE:PRLB – Get Rating) last announced its quarterly earnings results on Friday, May 6th. The industrial products company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.07. Proto Labs had a net margin of 7.01% and a return on equity of 4.19%. The firm had revenue of $124.20 million for the quarter, compared to the consensus estimate of $122.03 million. During the same period in the prior year, the firm posted $0.13 earnings per share. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Sell-side analysts expect that Proto Labs, Inc. will post 0.63 EPS for the current year.
Proto Labs Profile (Get Rating)
Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB – Get Rating).
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Insider Briggs Morrison Sells 62,292 Shares
State of Alaska Department of Revenue Sells 2,705 Shares of Macy’s, Inc. (NYSE:M)